XBIT — XBiotech Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1626878 ·
Last close
$2.40
Market Cap
$73.17M
52W High
$2.65
52W Low
$2.17
ADV30
25,298
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -6,274,000 | -5,505,000 | 139,836,000 | 115,459,000 | 4,819,000 |
| Dec 2025 | 0 | — | -29,755,000 | -26,892,000 | 150,082,000 | 125,551,000 | 9,732,000 |
| Sep 2025 | 0 | — | -6,047,000 | -6,008,000 | 172,424,000 | 147,367,000 | 5,344,000 |
| Jun 2025 | 0 | — | -6,336,000 | -1,756,000 | 178,682,000 | 152,938,000 | 5,618,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-39,920,000
Investing CF
$-289,000
Financing CF
$-10,250,000
CapEx
$-289,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.78
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-136,377,000
Inventory
—
Receivables
$360,000
ST Investments
—
EBIT TTM
$-45,217,000
Pretax Income TTM
$-45,305,000
Interest Exp TTM
$88,000
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -55,685,000 | -45,540,000 | 150,082,000 | 9,732,000 | — | -39,920,000 |
| Dec 2024 | 0 | -42,471,000 | -38,531,000 | 199,093,000 | 16,825,000 | — | -30,963,000 |
| Dec 2023 | 0 | -37,510,000 | -24,557,000 | 226,615,000 | 7,769,000 | — | -18,725,000 |
| Dec 2022 | 4,010,000 | -34,490,000 | -32,900,000 | 246,103,000 | 5,701,000 | — | -14,824,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.13
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | $73.50M | $7.59 | — |
| PRRUF | IMMUTEP Ltd | $73.69M | $0.05 | — |
| ATHE | ALTERITY THERAPEUTICS LTD | $73.95M | $4.08 | — |
| ACRV | Acrivon Therapeutics, Inc. | $71.48M | $1.67 | — |
| HYFT | MindWalk Holdings Corp. | $76.14M | $1.63 | — |
News headlines (Yahoo Finance, 1h cache)
XBiotech: Q4 Earnings Snapshot
2026-03-13 20:16 · Yahoo
3 Promising Penny Stocks With Market Caps Over $30M
2025-12-19 18:05 · Yahoo
November 2025's Promising Penny Stocks To Watch
2025-11-12 18:05 · Yahoo
XBiotech: Q3 Earnings Snapshot
2025-11-12 16:55 · Yahoo
XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 52% stake, while 36% is held by insiders
2025-08-28 10:04 · Yahoo
XBiotech: Q2 Earnings Snapshot
2025-08-13 18:55 · Yahoo
3 Promising Penny Stocks With Market Caps Above $90M
2025-07-02 18:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.